-
06.17.2026 | Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
GSK | GSK and Spero Therapeutics today announced that the US Food and Drug Administration (FDA) has approved Utebzi, an oral antibiotic for the treatment of complicated urinary tract infections (cUTIs) including pyelonephritisi, caused by certain susceptible pathogensii in adult patients who have limited or no alternative oral treatment options.
-
06.01.2026 | How Wockhardt created India’s first fully homegrown drug
FORBES INDIA | For decades, India excelled at making medicines invented elsewhere. With Zaynich, Wockhardt has become the first Indian pharma company to discover, develop, and own an FDA-approved drug.
-
04.24.2026 | A common stomach bug has become harder to treat
THE NEW YORK TIMES | A growing share of shigella infections are drug-resistant, the C.D.C. warns in a new report.
-
04.06.2026 | A mother’s loss — and a grandmother’s warning
KATIE COURIC MEDIA | My daughter Mallory should be here, living the life she fought so hard to stay in. Instead, I'm telling her story.
-
03.12.2026 | WHO releases guidance for urgently needed new antibiotics
CIDRAP | The World Health Organization (WHO) yesterday published blueprints to guide development of urgently needed new antibiotics for three types of bacterial infections.
-
03.10.2026 | Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn
THE GUARDIAN | The pipeline of new drugs to fight superbugs remains “worryingly thin” and has shrunk by 35% in the last five years, experts have said, predicting the annual number of deaths linked to drug-resistant infections globally will double to 8 million by 2050.
-
02.26.2026 | CARB-X targets 4 product themes for new funding round
CIDRAP | CARB-X today announced the product themes for its latest funding round.
-
02.23.2026 | Study: Antibiotic resistance threatens 30-year decline in deaths from lower respiratory infections
CIDRAP | A new analysis of global data shows that while deaths from lower respiratory infections (LRIs) declined from 1990 to 2021, deaths caused by antibiotic-resistant LRIs in 2021 were nearly three times higher than those caused by susceptible infections.
-
02.09.2026 | Updated PASTEUR Act reintroduced in Congress to boost antibiotic development
CIDRAP | A bipartisan group of US lawmakers is taking another shot at legislation that advocates hope could boost antibiotic development efforts.
-
01.28.2026 | Reviewing recently approved antibiotics for uncomplicated urogenital gonorrhea
CONTAGION LIVE | This past December, the FDA approved both zoliflodacin and gepotidacin for this sexually transmitted infection marking a significant advance amid rising antibiotic resistance. Here is an overview of the antibiotics.
-
01.22.2026 | New global consortium aims to transform antibiotic discovery to counter the growing AMR crisis
NOVO NORDISK FOUNDATION | Philanthropic partners invest US$60 million to support collaborative research to accelerate the discovery of next-generation antibiotics.
-
01.21.2026 | Antibiotic resistance could undo a century of medical progress – but four advances are changing the story
THE CONVERSATION | Imagine going to the hospital for a bacterial ear infection and hearing your doctor say, “We’re out of options.” It may sound dramatic, but antibiotic resistance is pushing that scenario closer to becoming reality for an increasing number of people.
Toggle navigation